To enhance the effectiveness of medical aid, the researchers are five recommendations: adoption of a clear set of standards for public health spending as a source and expenditure in other areas related to healthThey found that data on public spending on health are often absent for years, and can be difficult to reconcile. After overcoming the difficulties of data, the researchers identified two distinct trends. The researchers found that in these countries, governments that for every $ 1 invested in medical aid, moved between 43 cents and $ 1.14 from its own funds to other priorities. In contrast, in countries where NGOs receive more help and then apply to projects within the country, public health spending appears to have increased. These two trends deserve further research, the authors say.
The public financing of health in developing countries: a systematic cross-country analysis, the study appears online April 9-the first issue of The Lancet researchers analyzed expenditure data from developing countries e. health data on aid agencies, multilateral institutions like the World Health Organization and the International Monetary Fund, and hundreds of nonprofit groups and charities.
Considering the risks and benefits of health care extended to non-government sectors
study of the use of subsidies on world prices for products or transfers as mechanisms to help health
investing in the capacity of developing countries to receive and spend in an effective health aid
Throughout the national public health spending has doubled in low-income countries of 12 years to reach $ 18 billion in 2006, the study shows. And ‘three times the amount of development aid to the health of governments received.
If you look at the Canadian or European target LDL LDL targets, we achieved the target LDL much easier with ezetimibe 10 mg of atorvastatin combination. That even atorvastatin 40 mg. The European directives are a bit ‘tougher, he said Constance.
The commitment to the health of governments in developing countries has increased dramatically over the past two decades, according to a new study by the Institute for Health Metrics and Evaluation at the University of Washington, Harvard Medical School.
IHME further explore the cost national health care development path for health inputs, and the provision of health spending on international aid IHME next report, funding for global health in 2010, which will be published this summer.
We hope that the lessons learned from countries that invest most of their money in their health systems can be applied when the national health expenditure is declining, said Dr. Julio Frenk, the president and dean IHME Faculty, Harvard School of Public Health.
The worst is that people lose faith in support of health, especially now, as we see in places like Haiti, countries need more help to make a tangible difference in people’s lives.